MRI‐Guided High‐Intensity Focused Ultrasound as an Emerging Therapy for Stroke: A Review. Issue 1 (8th October 2018)

• Record Type: Journal Article
• Authors: Zafar, Atif; Quadri, Syed A.; Farooqui, Mudassir; Ortega‐Gutiérrez, Santiago; Hariri, Omid R.; Zulfiqar, Maryam; Ikram, Asad; Khan, Muhammad Adnan; Suriya, Sajid S.; Nunez‐Gonzalez, Joel R.; Posse, Stefan; Mortazavi, Martin M.; Yonas, Howard
• Is Part Of: Journal of neuroimaging. Volume 29:Issue 1(2019)
• Page Start: 5
• Page End: 13
• Publication Date: 2018-10-08
• Subjects: Focused ultrasound -- thermal ablation -- Insightec -- stroke -- hemorrhage; Diagnostic imaging -- Periodicals; Nervous system -- Diseases -- Diagnosis -- Periodicals; Imagerie pour le diagnostic -- Périodiques; Système nerveux -- Maladies -- Diagnostic -- Périodiques; Imagerie médicale; Neuroimagerie; Neurologie; Système nerveux; Périodique électronique (Descripteur de forme); Ressource Internet (Descripteur de forme); 616.804754
• DOI: 10.1111/jon.12568
• Languages: English
• ISSNs: 1051-2284

Abstract

ABSTRACT: Stroke, either ischemic or hemorrhagic, accounts for significantly high morbidity and mortality rates around the globe effecting millions of lives annually. For the past few decades, ultrasound has been extensively investigated to promote clot lysis for the treatment of stroke, myocardial infarction, and acute peripheral arterial occlusions, with or without the use of tPA or contrast agents. In the age of modern minimal invasive techniques, magnetic resonance imaging‐guided high‐intensity focused ultrasound is a new emerging modality that seems to promise therapeutic utilities for both ischemic and hemorrhagic stroke. High‐intensity focused ultrasound causes thermal heating as the tissue absorbs the mechanical energy transmitted by the ultrasonic waves leading to tissue denaturation and coagulation. Several in‐vitro and in‐vivo studies have demonstrated the viability of this technology for sonothrombolysis in both types of stroke and have warranted clinical trials. Apart from safety and efficacy, initiation of trials would further enable answers regarding its practical application in a clinical setup. Though this technology has been under study for treatment of various brain diseases for some decades now, relatively very few neurologists and even neurosurgeons seem to be acquainted with it. The aim of this review is to provide basic understanding of this powerful technology and discuss its clinical application and potential role as an emerging viable therapeutic option for the future management of stroke.